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Given the prevalence of relapsing fever (RF) in
Senegal, this disease may cause illness and death in other
areas of West Africa. We performed a cross-sectional, clin-
ic-based study to investigate the presence of RF in Togo
during 2002–2004. Blood samples from patients with fever
were examined for RF spirochetes by microscopy, PCR,
and DNA sequencing of amplicons and for antibodies to
the glycerophosphodiester phosphodiesterase antigen.
Although no spirochetes were seen in blood smears, ≈10%
of the patients were positive by PCR and ≈13% were
seropositive for spirochetes. DNA sequencing demonstrat-
ed that Borrelia crocidurae and B. duttonii were present.
Most patients were treated for malaria whether or not plas-
modia were observed. Thus, many RF patients originally
had a misdiagnosis of malaria, which resulted in ineffective
treatment. The inability of microscopic analysis to detect
spirochetes compared with PCR demonstrates the need for
tests with greater sensitivity.
S
pirochetes of the genus Borrelia are known to cause 2
major types of human disease, Lyme disease, which
occurs primarily in temperate regions, and relapsing fever
(RF), which occurs in both temperate and tropical regions.
Many vertebrates serve as enzootic hosts for the bacteria,
and borreliosis is related to climatic and other environmen-
tal parameters required for the vectors and reservoir hosts
(1,2). Borrelia-related disease is endemic in tropical and
subtropical regions; B. hermsii and B. turicatae cause tick-
borne RF (TBRF) in North America. In Europe, TBRF is
uncommon; B. hispanica is the causative agent in Spain,
Portugal, Greece, and Cyprus (3,4).
TBRF in Africa is caused primarily by B. duttonii,
which is transmitted by Ornithodoros moubata ticks in
East and Central Africa, and by B. crocidurae, which is
transmitted by O. sonrai in West Africa. Humans are the
only known vertebrate host for B. duttonii. B. crocidurae is
maintained in enzootic cycles in rodents and other small
mammals. African TBRF is associated with proximity to
tick-infested burrows and huts (4–6).
The primary clinical manifestations of RF are recur-
rent high fever interrupted by afebrile periods,
hepatomegaly, splenomegaly, and anemia. These signs are
similar to those of malaria. The fever peaks are associated
with high spirochetemias, and antigenic variation leads to
new antigenic variants of a major surface protein and the
recurrence of high numbers of borreliae in the blood
(7–10). When patients have high fever, spirochetes may
achieve sufficiently high cell densities in the blood to be
observed directly by microscopy when wet mounts of
blood or Giemsa-stained blood smears are examined.
Between peaks, the bacteria are too scarce to be visualized
in the blood. Treatment with various antimicrobial drugs is
effective (5,6); however, borreliae may rapidly invade the
brain, and infection of the central nervous system may per-
sist if not treated or if treated with antimicrobial drugs that
do not readily penetrate the blood-brain barrier (5).
Research on RF in Africa has been limited, and little
is known regarding the presence and geographic distribu-
tion of the spirochetes and tick vectors. Studies in Senegal
indicate that RF is widely distributed and prevalent in this
country; investigators speculate that RF may cause illness
in rural areas throughout much of West Africa (11). A 2-
year prospective investigation in a rural community in the
Senegalese savanna showed that 10% of the study popula-
tion became infected during the study period, resulting in
an incidence of 5.1% (12). A recent 14-year longitudinal
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is a common cause of fever in most rural areas of Senegal
as well as in some regions of Mauritania and Mali (13). In
other areas of West Africa, where RF has not been identi-
fied, the disease is generally not considered in the diagno-
sis when patients have a fever.
We hypothesized that RF caused by B. crocidurae
may be present in other areas of West Africa where the cli-
mate and environment are similar to that of Senegal.
However, because of the lack of knowledge, diagnostics,
and the high prevalence of malaria in these areas, RF
remains undetected (14). Therefore, we conducted a study
in Togo to determine if patients with fever might have RF.
The study included examination of blood by direct
microscopy, molecular methods, and serologic analysis.
Methods
Setting
Clinics participating in the study were located in the
northern dry savannah and the southern tropical high
plateau of Togo. The clinics were at the children’s hospital,
Hopital d’Enfants, in Dapaong (urban/semiurban) in north-
ern Togo and rural clinics in southern Togo, including the
Centre Medico-Social de Sodo in Sodo, Hopital Bethesda,
Agou Clinic in the Agou area, and the general hospital in
Kpalimé, a town with ≈50,000 inhabitants (Figure).
Participants
Interviews and sampling were conducted from March
2002 through September 2004; sampling was performed
from August through October in 2003 and 2004 in north-
ern and southern Togo, respectively. Trained laboratory
personnel in various clinics obtained blood samples, con-
ducted interviews, and performed microscopic analyses. A
total of 244 persons with fever were randomly selected; 14
persons without fever were included as controls.
Procedures
Aquestionnaire that contained information on demog-
raphy, living conditions such as building materials that
may be favorable for nesting ticks and rodents, and occu-
pation was used in interviews. Axillary temperature of
each patient with fever was measured. Blood was collect-
ed from the arm by venipuncture or from a finger by lancet
stick and applied to glass microscope slides. Thick and thin
blood smears were stained with Giemsa and analyzed by
microscopy at a magnification of 1,000× for plasmodia
and at 400× for spirochetes. Microscopic examination for
spirochetes was used at the clinics to enable diagnosis on
site by the method routinely used in Senegal (14,15).
Approximately 300 fields were examined to detect
malaria parasites and borreliae. For malaria diagnosis,
samples were examined for trophozoites and gametocytes.
Blood and serum samples were stored at −20°C and
shipped frozen to Sweden for further testing.
Plasmid Cloning and Protein Expression
Genomic DNAfrom B. crocidurae was used as a tem-
plate for amplification of the glycerophosphodiester phos-
phodiesterase (glpQ) gene and subsequent sequence
analysis (Table 1). The PCR amplification product was
digested with BamHI and XhoI and cloned into the pET-
15b vector (Novagen, Madison, WI, USA) as previously
described (16). The resulting recombinant plasmid was
transformed into the Rosetta strain of Escherichia coli.
The heterologously produced histidine (His)–tagged GlpQ
fusion protein was purified by using Ni-NTAspin columns
(Qiagen, Valencia, CA, USA), and the protein concentra-
tion was determined with Bradford assay (Bio-Rad
Laboratories, Hercules, CA, USA).
ELISA with Recombinant GlpQ Protein
An ELISAwas used to detect anti-GlpQ immunoglob-
ulin G (IgG) antibodies in patient sera and was performed
as described by Porcella et al. (16). Briefly, His-GlpQ pro-
tein was adsorbed onto microtiter well surfaces of Ni-NTA
HisSorb plates (Qiagen). Wells were blocked with diluent
to inhibit nonspecific binding and washed. Serum samples
were tested at a 1:100 dilution by incubating 100 µL/well
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Figure. Locations of clinics in Togo involved in the study: 1,
Dapaong; 2, Sodo; 3, Kpalimé; 4, Agou; 5, Bethesda; 6, sites of
the community study in the Sodo region (adapted from
www.maps.com).for 1 h at room temperature. After 3 washes, 100 µL of a
1:2,500 dilution of goat anti-human IgG (heavy and light
chains) conjugated to horseradish peroxidase (Kirkegaard
and Perry Laboratories, Gaithersburg, MD, USA) was
added to each well and incubated for 1 h. After 3 washes,
50% 2,2′-azino-di-(3-ethyl-benzthiazoline sulfonate) sub-
strate was added and incubated for 25 min before analysis
at 405 nm with a Multiskan microtiter plate reader
(Labsystems, Vantaa, Finland). Each serum sample was
tested in triplicate, and the mean absorbance value was
determined. Samples were considered positive if their
mean absorbance was greater than the mean plus 3 stan-
dard deviations of the absorbance of control sera tested at
the same dilution. Serum samples from Ethiopian patients
with RF were included as positive controls (16).
Blood Screening by Nested PCR
Blood samples that were positive or borderline posi-
tive by ELISA were tested by a nested PCR for Borrelia
DNA. DNA was purified from the blood samples and 4
primers (Table 1) were used for detection of the 16S rRNA
gene of borreliae. The first PCR amplified a 584-bp region
of the gene with the primers Nested_1_F – Nested_1_R.
The second PCR amplified a 498-bp region with the
primers Nested_2_F – Nested_2_R. The amplicons
obtained from the nested PCRs were sequenced to identify
the Borrelia species because the primers were not able to
amplify DNA from specific species of RF spirochetes.
PCR and Sequencing
For amplification of the complete coding sequence of
glpQ gene from B. duttonii, 2 primers were designed by
using B. hermsii noncoding sequences flanking the glpQ
gene and 4 primers were designed by using sequences
within the gene (Table 1). Nested PCR primers (Table 1)
were designed to target the 16S rRNA gene. The PCR
product for the B. duttonii glpQ gene was sequenced, and
data were deposited in GenBank (accession no.
DQ909058).
Ethics
The study was approved by the Ethics Committee at
Umeå University (Dnr 04–050 M). Informed consent was
obtained at clinics from all patients or from the accompa-
nying parent if the patient was a child.
Statistical Analysis
Proportions were compared with a 2-tailed χ2-correct-
ed (Yates) analysis and Fisher exact test. p values <0.05
were considered significant.
Results
No patients were positive for borreliae by microscop-
ic examination of Giemsa-stained blood smears. Among
patients with fever, 9 (10%) of 90 children in northern
Togo, and 5 (9.8%) of 51 children and 16 (16.3%) of 98
adults in southern Togo were seropositive by ELISA. A
total of 12.6% of patients with fever were positive by
ELISA (Table 2). For those patients without fever, 2
(14.3%) of 14 were seropositive. Because the glpQ gene is
present in RF spirochetes but not in Lyme disease spiro-
chetes, the positive serologic results strongly suggest that
patients were infected with RF spirochetes (11). However,
this serologic test is not species specific and cannot distin-
guish current from past infections.
Current Borrelia infections were detected by PCR and
16S rRNA gene sequence analysis in blood samples of
patients from both northern and southern Togo. DNA
sequencing identified both B. crocidurae and B. duttonii,
but B. duttonii was found only in patients from northern
Togo (Table 2). All 81 patients from northern Togo who
were seronegative were also negative by PCR. In contrast,
8 (88.9%) of 9 patients who were positive by ELISA were
also positive by PCR (p<0.05). All patients who were pos-
itive by PCR had a fever when their blood samples were
collected.
A total of 28 patients from southern Togo were tested
for current spirochetemias and included all ELISA-posi-
tive and some ELISA-negative patients. The negative
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the cut-off value as well as randomly chosen samples with
lower values. The 13 PCR-positive patients included 11
(55%) of 20 ELISA-positive patients and 2 (25%) of 8
ELISA-negative patients. Two samples from ELISA-posi-
tive patients could not be tested by PCR because the DNA
was degraded. Both patient samples that were PCR posi-
tive and ELISAnegative had ELISAvalues just below cut-
off value used in the study.
All patients from northern Togo were children (age
range <1–14 years). For children <4 years of age, 6 (10%)
of 60 were seropositive. Of these children, 5 had a fever
and 4 had an active Borrelia infection detected by PCR.
DNA sequence analysis showed that 3 children were
infected with B.  crocidurae and 1 with B.  duttonii. In
southern Togo, 1 (9.1%) of 11 children <1–4 years of age
were seropositive. The overall male-to-female ratio among
study patients was 1.3:1. Serologic and PCR results did not
differ by sex, ethnic background, or profession, with the
exception of cow herders. The prevalence of seropositive
adults was 62.5% (5/8) among cow herders compared with
12.2% (11/90) among those in other professions (p<0.05);
11 (78.6%) of 14 adults in the Peuhl ethnic group were
cow herders (95% confidence interval [CI] 49.2%–95.3%),
and 4 of 5 ELISA-positive Peuhl were cow herders. Atotal
of 10.8% (95% CI 5.9%–17.8%) of all adults studied were
cow herders. More Borrelia-infected patients lived in
houses made of mud rather than cement than persons with-
out RF infection (p = 0.008, data not shown).
The prevalence of malaria among patients with fever
was 63.1%. Of 21 patients with PCR-confirmed Borrelia
infections, malaria was diagnosed for 7 on the basis of a
positive blood smear. Therefore, 7 (4.5%) of 154 patients
were coinfected with malaria parasites and Borrelia
(Table 3). In the youngest children (<4 years of age), 4 of
5 Borrelia-infected children also had malaria. 
In northern Togo, patients infected with malaria and
Borrelia were treated primarily with chloroquine,
artemether, quinine, and amoxicillin. Borrelia-infected,
malaria-negative patients were treated primarily with
chloroquine, quinine, or amoxicillin. In southern Togo,
patients with malaria and Borrelia infections were treated
primarily with quinine and chloramphenicol for typhoid
fever, metronidazole for amebiasis, and albendazole for
digestive parasitosis. Borrelia-infected, malaria-negative
patients were treated with chloroquine and antimicrobial
drugs, such as amoxicillin, which are ineffective against
RF Borrelia (Table 3) (14).
Discussion
Although microscopic analysis of Giemsa-stained
blood smears for Borrelia showed negative results, current
infections were demonstrated by PCR and gene sequenc-
ing in 8.8% of patients with fever. Therefore, no RF infec-
tions would have been detected if only microscopic
examination of stained blood smears had been performed.
Our results emphasize the low sensitivity of microscopy in
the diagnosis of RF, as has demonstrated by others
(11,14,17). Another problem in diagnosis is that the borre-
liae are detectable only during the short peaks of fever
(18). Microscopy might have shown positive results if
dark-field or fluorescent microscopy had been used, but
this was not possible in the clinics in this study. However,
1 of the primary objectives of this study was to improve
the diagnosis of RF borreliosis by using molecular and
serologic techniques.
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Borrelia infections were false negative by microscopy
(11). Microscopy is the method routinely used to diagnose
B. crocidurae infections in Senegal, where the disease is
common (14,15). Thus, methods that provide greater sen-
sitivity are needed to determine more accurately the pres-
ence of RF throughout West Africa. Since the GlpQ
antigen is present in RF Borrelia but absent in Lyme dis-
ease Borrelia, positive antibody test results strongly indi-
cated that infections with RF Borrelia were occurring or
had occurred (16). However, the infecting species and the
time of infection could not be determined by this method.
Positive serologic test results correlated with current infec-
tion, as demonstrated by PCR and sequence analysis.
Thus, serologic tests may be more adequate for diagnosis,
although ELISAprocedures would have to be modified for
use in small rural clinics.
Our finding of TBRF in Togo demonstrates that the
geographic distribution of this disease in West Africa is
greater than previously thought. Trape et al. suggested that
RF caused by B. crocidurae might be spreading to new
areas because of the sub-Saharan drought, which might
allow vector ticks to colonize new areas in the savannas of
West Africa (2). Our results suggest that this might be true.
We also found RF caused by B. crocidurae in the tropical
region of southern Togo, where the climate may be less
favorable for its tick vector. Thus, habitats believed to be
preferred by O.  sonrai may need to be reconsidered.
Southern Togo has been subjected to deforestation, periods
of drought, and slash-and-burn agriculture. During the
rainy season, the average temperatures in Dapaong and
Atakpame are 24°C and 25.8°C, respectively, compared
with dry season mean temperatures of 28.9°C and 26.8°C,
respectively (19). The dry wind or harmattan from the
Sahara Desert during winter can cause periodic droughts in
northern Togo. We propose that areas with similar climate
in West Africa are likely to have TBRF.
Of particular interest was our finding of B. duttonii in
northern Togo, which extends the known distribution of
this species in Africa. Additional work is needed to deter-
mine if its vector O. moubata is present in northern Togo
or if B duttonii can be transmitted by O. sonrai. More stud-
ies are needed to determine the distribution of RF spiro-
chetes and their vectors in Africa and what effect these
infections have on human health.
Many of the primary symptoms of malaria and RF are
similar, such as recurrent fever, chills, anemia,
hepatomegaly, splenomegaly, and possible neurologic
symptoms. Thus, a considerable risk for misdiagnosis of
TBRF as malaria exists in countries in which RF is not rec-
ognized but in which malaria is prevalent. Occasional
reports of European tourists returning home from Senegal
with B. crocidurae infections have implied that the disease
may be misdiagnosed as malaria, which leads to incorrect
treatment (14,15,20). Because RF has not been investigat-
ed in most West African countries including Togo, the dis-
ease is generally not considered in a differential diagnosis
for fever patients. Also, malaria is often diagnosed on the
basis of only clinical symptoms, not examination for para-
sites in the blood, which increases misdiagnosis. Increased
knowledge of the geographic distribution and epidemiolo-
gy of RF in West Africa should improve the recognition
and treatment of this disease. Prompt diagnosis of RF
would also reduce the number of people in whom chronic
symptoms such as neuroborreliosis later develop when
bacteria cross the blood-brain barrier and infect the central
nervous system (5,21,22).
We used a questionnaire to determine possible risk
factors associated with RF. Some children <1–<4 years of
age were infected with RF Borrelia. Since O. sonrai is
nocturnal, feeding mostly at night, these children may have
been infected at home. However, RF among infants may
also reflect infection from mothers before or during birth,
as occurs with B. duttonii in East Africa (18). We also
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often lived in houses made of mud rather than cement. This
observation is similar to ones in Senegal, where
Ornithodoros ticks feed primarily at night inside mud or in
adjacent areas where small mammals are present (2,6,20). 
Before our study, we trapped 66 rodents and insecti-
vores in or near houses in Togo. Four species were identi-
fied: musk shrew (Crocidura spp.), Nile rat (Arvicanthis
niloticus), multimammate rat (Mastomys natalensis), and
brown rat (Rattus norvegicus); 3 are known reservoirs for
B. crocidurae in Senegal. These findings showed the pres-
ence of these potential reservoirs in northern and southern
Togo (unpub. data). We found that mud huts were associ-
ated with entrances of rodent burrows, which might
increase the risk for exposure to ticks (data not shown). In
the present study, cow herders were also at a greater risk of
acquiring RF. However, more studies are required to inves-
tigate potential risk groups. A higher proportion of cow
herders who were ELISA positive were also Peuhl, who
are nomadic people. Their behavior and sleeping outside at
night may put them at greater risk of being bitten by noc-
turnal soft ticks.
We report TBRF in Togo with a prevalence of 8.8%
among the patients studied. For those with fever, 63.1%
had malaria and 4.5% were coinfected with RF Borrelia.
Among those with RF, 33.3% were coinfected with malar-
ia parasites. Given the retrospective finding of spirochetes
by PCR, only 1 of 18 patients with TBRF received treat-
ment effective against this disease at the time she was seen
in the clinic. Thus, TBRF is obscured by the high incidence
of malaria in Togo, and this problem likely occurs in other
regions in West Africa. In rural health centers without lab-
oratory facilities, diagnosis of malaria is based only on
clinical symptoms. The potential risk for misdiagnosis and
ineffective treatment of patients with RF rather than malar-
ia needs to be addressed. Our findings demonstrate the
need for improved diagnostic procedures to detect TBRF
in West Africa. We consider the high prevalence of RF
among febrile children and the lack of correct treatment as
important health concerns, particularly with regard to the
severity of untreated neuroborreliosis and women infected
during pregnancy.
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